Rolls-Royce $600M investment took two years to hammer out
Company executives first broached the subject with state officials during a trade mission to the United Kingdom to take in the Farnborough International Airshow.
Company executives first broached the subject with state officials during a trade mission to the United Kingdom to take in the Farnborough International Airshow.
Rolls-Royce Corp. is planning a wide-scale modernization of its Tibbs Avenue jet-engine plant in Indianapolis that would be part of an overall goal to invest nearly $600 million in its local operations over five years.
Building or investing in sports facilities in order to boost finances at a university is nearly always a losing play, according to financial experts.
American Senior Communities has fired its chief operating officer and accepted the resignation of its chief financial officer—17 days after an FBI raid of its offices and the home of its former CEO James Burkhart.
The coding academy and consulting firm has agreed to lease 2,742 square feet of space for one year at the new Launch Fishers facility at 12175 Visionary Way.
Health care providers say they can’t attract patients tomorrow with facilities from yesterday. So they are scrambling to erect new structures that are more convenient.
Does Indiana face a shortage of schoolteachers? You’d certainly think so from news stories showing an 18-percent decline in new teacher licenses issued over the past five years.
Including the latest grant, the Lilly Endowment has given more than $38 million to BioCrossroads since the life sciences business development group was founded in 2002.
Evergreen Investment Corp. bought the four-building Waterplace Park from Indianapolis-based Keystone Realty Group, which purchased the property out of receivership in January 2014.
After Anthem CEO Joe Swedish argued that his $54 billion purchase of Cigna Corp. wouldn’t harm competition, execs at some of Indiana’s most prominent health care and health insurance institutions expressed skepticism last week during the IBJ Health Care Power Breakfast.
The settlement with France-based Sanofi SA clears up uncertainty over a drug that could rack up more than $1 billion in sales by 2020, according to Wall Street analysts.
John Lechleiter, CEO of Eli Lilly and Co., said the company remained confident about its drug pipeline even after it weathered a string of failed clinical trials.
Eugene White, the president of Martin University, had become restless in retirement when the opportunity to lead the struggling black liberal arts college surfaced.
Paul Baltzell, the state of Indiana's chief information officer, is excited about the power of data analytics to improve the effectiveness of government.
Simon Property Group executive David Contis says technology will enhance, not kill, bricks-and-mortar retail.
Crystal Grave, CEO of the event-planning search engine Snappening, gained new perspective on the Indy tech community after spending time in Silicon Valley.
Hillary Clinton said she would give close scrutiny to health-insurance industry mergers like those proposed this year by Anthem Inc. and Aetna Inc., part of the Democratic presidential candidate’s latest policy plans.
It looks like Eli Lilly and Co. finally has a drug that can replace its former stars Zyprexa and Cymbalta. The most bullish analysts think Jardiance can surpass those $5 billion-a-year blockbusters.
Requiring a delicate balance of whimsy, theatrics and sincerity, the musical has its problems. But it can thrive when planted in the proper theater and given appropriate watering.